WaveMan
WaveMan · Company
MDLN · Medline Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

MDLN Medline (MDLN) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0002046386
Quote by TradingView
C-suite buying · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
325
13F, latest reported quarter
Conversions, 180 days
7
Codes C/M, not in net · $0 priced

What the filings say about MDLN

Insiders, 180 days
-$4.8B net sold
1 buyer · 5 sellers · 0% of sales under a 10b5-1 plan

Medline insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Medline Inc. insiders sold a net $4.8B of stock across 55 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
GIC Private Ltd
SELL
2026-10-13 SECtraded 2026-10-08
7,816,987
$274.8M
-5.1%
Context
  • 11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Oct 6, 2026.
  • The trade is 11.3% of the 69,408,506 shares held after it.
  • No other insider sold within 30 days.
  • 325 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider GIC Private Ltd sold about $274.8M of MDLN on Oct 8, 2026; 325 funds added in the latest 13F quarter.
GIC Private Ltd
SELL
2026-10-06 SEC
2,088,987
$73.2M
-3.8%
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Oct 5, 2026.
  • The trade is 12.7% of the 16,453,806 shares held after it.
  • No other insider sold within 30 days.
  • 325 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider GIC Private Ltd sold about $73.2M of MDLN on Oct 6, 2026; 325 funds added in the latest 13F quarter.
GIC Private Ltd
SELL
2026-10-06 SEC
7,183,013
$251.8M
-3.8%
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Oct 5, 2026.
  • The trade is 9.3% of the 77,225,493 shares held after it.
  • No other insider sold within 30 days.
  • 325 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider GIC Private Ltd sold about $251.8M of MDLN on Oct 6, 2026; 325 funds added in the latest 13F quarter.
GIC Private Ltd
SELL
2026-10-06 SECtraded 2026-10-05
1,688,690
$60.4M
-3.8%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Oct 2, 2026.
  • The trade is 9.1% of the 18,542,793 shares held after it.
  • No other insider sold within 30 days.
  • 325 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider GIC Private Ltd sold about $60.4M of MDLN on Oct 5, 2026; 325 funds added in the latest 13F quarter.
GIC Private Ltd
SELL
2026-10-06 SECtraded 2026-10-02
2,570,999
$90.9M
-3.8%
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Aug 14, 2026.
  • The trade is 12.7% of the 20,231,483 shares held after it.
  • No other insider sold within 30 days.
  • 325 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider GIC Private Ltd sold about $90.9M of MDLN on Oct 2, 2026; 325 funds added in the latest 13F quarter.
55 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 50 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$4.8B over 180 days
-$1.2B over 90 days · -$4.8B of it by a 10%+ holder
the lowest in Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
325 funds bought in last quarter
more than 89% of Medical Devices
Revenue
+11.5% year over year
more than 53% of Medical Devices
Margin
4.1% net margin
more than 73% of Medical Devices
Buybacks
$33.0M repurchased, FY to 2025-12-31
below 53% of Medical Devices
Short interest
14.3% of the float short (float per yahoo 2026-10-26) · 5.1 days to cover · settled 2026-09-30
What changed in the last 30 days
Oct 13Insider GIC Private Ltd sold $996.4M (6 trades, Oct 2 to Oct 8)

Watch MDLN

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-16.9%12M
-23%-8%+7%+22%2025-122026-022026-032026-052026-072026-082026-10 2026-03-10 · CG Subsidiary Holdings L.L.C. sold $1.1B2026-03-10 · CPEP Circle Holdings L.P. sold $1.1B2026-03-10 · CP Circle ML-5 Holdco, L.P. sold $1.1B2026-03-10 · TC Group Cayman Investment Holdings Sub L.P. sold $1.1B2026-05-28 · BCP 8 Holdings Mozart Manager L.L.C. sold $720.3M2026-05-28 · BX Mozart ML-2 Holdco GP L.L.C. sold $720.3M2026-03-10 · Blackstone Group Management L.L.C. sold $667.6M2026-03-10 · Mozart Aggregator II UNLV Holdco L.P. sold $667.6M2026-05-28 · Mend Partners II, L.P. sold $655.8M2026-03-10 · HFCP X (Parallel-A), L.P. sold $593.1M2025-12-18 · CPEP GP, LLC sold $555.0M2025-12-18 · Carlyle Mozart Coinvestment Holdings, L.P. sold $555.0M2025-12-18 · CG Subsidiary Holdings L.L.C. sold $555.0M2026-05-28 · Mend Partners II, L.P. sold $435.0M2026-03-10 · HFCP X (Parallel-A), L.P. sold $397.1M2025-12-18 · BCP Mozart Aggregator L.P. sold $381.9M2025-12-18 · GIC Special Investments Pte Ltd bought $365.0M2026-05-28 · BCP 8 Holdings Mozart Manager L.L.C. sold $360.2M2026-05-28 · BX Mozart ML-2 Holdco GP L.L.C. sold $360.2M2026-03-10 · Blackstone Group Management L.L.C. sold $333.9M2026-03-10 · Mozart Aggregator II UNLV Holdco L.P. sold $333.9M2025-12-18 · GIC Special Investments Pte Ltd sold $289.5M2026-10-08 · GIC Private Ltd sold $274.8M2026-10-06 · GIC Private Ltd sold $251.8M2026-10-02 · GIC Private Ltd sold $245.4M2025-12-18 · HFCP X (Parallel-A), L.P. sold $144.1M2026-10-02 · GIC Private Ltd sold $90.9M2026-05-28 · BCP 8 Holdings Mozart Manager L.L.C. sold $82.5M2026-05-28 · BX Mozart ML-2 Holdco GP L.L.C. sold $82.5M2026-03-10 · Blackstone Group Management L.L.C. sold $76.4M2026-03-10 · Mozart Aggregator II UNLV Holdco L.P. sold $76.4M2025-12-18 · Mills Andrew J. bought $75.0M2026-10-06 · GIC Private Ltd sold $73.2M2025-12-18 · Mills Charles N. bought $70.8M2026-08-05 · GIC Private Ltd sold $60.7M2026-10-05 · GIC Private Ltd sold $60.4M2026-05-28 · BCP 8 Holdings Mozart Manager L.L.C. sold $54.4M2026-05-28 · BX Mozart ML-2 Holdco GP L.L.C. sold $54.4M2026-08-13 · GIC Private Ltd sold $53.7M2026-03-10 · Blackstone Group Management L.L.C. sold $50.5M2026-03-10 · Mozart Aggregator II UNLV Holdco L.P. sold $50.5M2026-05-28 · Mend Partners II, L.P. sold $46.1M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns MDLN: institutional holders (13F)

13F holdings, latest reported quarter
Carlyle Group Inc.
187,083,713 sh
$7.4B
Blackstone Inc.
101,791,008 sh
$4.0B
H&F Corporate Investors X, Ltd.
70,874,326 sh
$2.8B
FMR LLC
46,963,203 sh
$1.9B
Capital Research Global Investors
39,963,790 sh
$1.6B

Congress trades in MDLN

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

MDLN planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

MDLN mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Renaissance IPO ETF
$9.0M position · as of 2026-06-30
5.0%
Advantage Portfolio
$11.8M position · as of 2026-06-30
4.3%
Transamerica Capital Growth
$46.3M position · as of 2026-07-31
4.1%
Transamerica Morgan Stanley Capital Growth VP
$6.0M position · as of 2026-06-30
3.6%
Growth Portfolio
$18.7M position · as of 2026-06-30
3.3%
Global Permanence Portfolio
$1.5M position · as of 2026-06-30
3.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Medline, Inc. Political Action Committee (Medline Pac)
Cycle 2026 · $0K spent
-
Federal Election Commission, matched by the PAC's connected organisation
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $4.8B sold by insiders over 180 days, 325 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

MDLN financials

Revenue growth
+11.5%
XBRL, annual
Net margin
4.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Debt to equity
1.09x
long-term 2026-06-27 plus current 2026-06-27; equity 2026-06-27
Cash flow to debt
n/a
needs four quarters of operating cash flow
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-12
Revenue$28.4B$25.5B$23.2B
Gross profit$7.5B$7.0B$5.9B
Operating income$2.2B$2.1B$1.2B
Net income$1.2T$1.2B$234.0M
EPS (diluted)-0.01n/an/a
Operating cash flow$1.7B$1.8B$1.7B
Cash$1.9B$199.0Mn/a
Long-term debt$12.5B$16.4Bn/a
Buybacks$33.0M$20.0M$0
SEC XBRL, fiscal years, as known on 2026-10-27

MDLN Stock Sonar score 5/7 axes

Find similar shapesCompare

MDLN ranks highest on institutional and government (90th percentile) and risk and compliance (55th), and lowest on financial health (16th), among Medical Devices peers.

HealthGrowthInsidersInstitutionsRisk
Financial health
16
Inputs
  • Debt to equity1.09x · 16 pct, sector of 159
  • Cash flow to debtneeds four quarters of operating cash flow
Growth
53
Inputs
  • Revenue growth, YoY+11.5% · 53 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
26
Inputs
  • Net Form 4 buying (codes P and S), 180d-$4.8B · 0 pct, sector of 140
  • Insider buyers, 180d1 · 52 pct, sector of 142
Institutional and government
90
Inputs
  • Funds adding, latest quarter325 · 89 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$1.9M · 90 pct, sector of 50
Risk and compliance
55
Inputs
  • Short interest, % of float+14.3% · 10 pct, sector of 240
  • Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 116
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Profitability, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

MDLN filings, in plain words

Are Medline insiders buying or selling MDLN?

In the 180 days to 2026-10-27, Medline insiders were net sellers, a net $4.8B: $170.8K of purchases and $4.8B of sales reported on Form 4, by 1 buyer and 5 sellers.

Read the full summary

In the 180 days to 2026-10-27, Medline insiders were net sellers of MDLN, a net $4.8B across purchases and sales reported on Form 4 by 1 buyer and 5 sellers. Most of that figure, $4.8B, came from a holder of 10% or more rather than an officer or director. Sales outweighed purchases more than tenfold by value. None of the 26 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies